Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Wafaa El Metnawy"'
Autor:
Anurag Mehta, Rodney J. Scott, Wafaa El Metnawy, Gabriel de Souza Macedo, Pavel S. Borisov, Ravindran Kanesvaran
Publikováno v:
Oncotarget
Patients with metastatic castration-resistant prostate cancer (mCRPC) have an average survival of only 13 months. Identification of novel predictive and actionable biomarkers in the homologous recombination repair (HRR) pathway in up to a quarter of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3ba6abf489ee4daf6da5ee64c31de34
http://europepmc.org/articles/PMC8351605
http://europepmc.org/articles/PMC8351605
Autor:
Yasser El Nahass, Heba Nader, Salwa Sabet, Hend Nooh, Heba Bassiony, Mahmoud Kamel, Mohamed Samra, Hossam Mahmoud, Wafaa El Metnawy, Fatma El Refaey
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 23(3)
Prognostication of AML patients depends on association of genetic and epigenetic abnormalities. We aimed to evaluate the frequency and prognostic significance of Additional Sex comb's Like1 (ASXL1), Isocitrate Dehydrogenase (IDH) and Casitas B- linea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bcfbe22ac62882628338298782bb5d1
https://pubmed.ncbi.nlm.nih.gov/35345371
https://pubmed.ncbi.nlm.nih.gov/35345371
Autor:
Hossam K, Mahmoud, Yasser, El Nahas, Mohamad, Abdel Moaty, Raafat, Abdel Fattah, Mohamad, El Emary, Wafaa, El Metnawy
Publikováno v:
International Journal of Biomedical Science : IJBS
Purpose: To assess the kinetics of molecular response to Imatinib Mesylate (IM) therapy in predicting progression free survival (PFS), sustained hematological, and cytogenetic responses in CPCML. Methods: Ninety five newly diagnosed CPCML Egyptian pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bb236164789010ce4bcb1f515d330051
https://pubmed.ncbi.nlm.nih.gov/23675141
https://pubmed.ncbi.nlm.nih.gov/23675141